Roxybond Tablet, Coated
Product Images NDC 81140-104

7 FDA label images from Protega Pharmaceuticals Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Roxybond (NDC 81140-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Protega Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Rox02 0010 01)

Figure 1 (Rox02 0010 01)
A line graph showing drug liking visual analog scale (VAS) scores over 24 hours for crushed intranasal oxycodone immediate-release tablets, crushed intranasal ROXYBOND, intact oral ROXYBOND, and placebo. The y-axis represents drug liking VAS in millimeters, and the x-axis shows time in hours. Four lines compare the drug liking profiles of these formulations over time.*
FDA Label Image

Structural Formula (Rox02 0010 02)

Structural Formula (Rox02 0010 02)
Chemical structure of oxycodone hydrochloride showing its molecular arrangement, including rings, hydroxyl, methyl groups, and hydrochloride ion. The molecular formula is C18H21NO4 with HCl, and molecular weight is 351.82.*
FDA Label Image

Figure 2 (Rox02 0010 03)

Figure 2 (Rox02 0010 03)
A pharmacokinetic concentration-time curve showing plasma concentration (ng/mL) versus time (hours) for RoxyBond tablets at 5 mg, 15 mg, and 30 mg strengths. The graph illustrates how drug concentration peaks and declines over a 24-hour period for each strength.*
FDA Label Image

Principal Display Panel – 5 mg Bottle Label (Rox02 0010 04)

Principal Display Panel – 5 mg Bottle Label (Rox02 0010 04)
Label for RoxyBond 5 mg tablets containing oxycodone hydrochloride, oral coated tablets, available in a 100-tablet package. The label states the strength as 5 mg, includes the NDC number 81140-101-10, and notes that the medication is Rx only. Manufactured by Protega Pharmaceuticals Inc, Princeton, NJ. Identification markings for the tablet are shown and storage instructions are provided.*
FDA Label Image

Principal Display Panel – 15 mg Bottle Label (Rox02 0010 05)

Principal Display Panel – 15 mg Bottle Label (Rox02 0010 05)
Label for RoxyBond 15 mg coated tablets containing oxycodone hydrochloride. The label indicates 100 tablets per bottle, prescription only, manufactured by Protega Pharmaceuticals Inc. Storage instructions and identification markings for the tablets are also shown.*
FDA Label Image

Principal Display Panel – 30 mg Bottle Label (Rox02 0010 06)

Principal Display Panel – 30 mg Bottle Label (Rox02 0010 06)
Label for RoxyBond 30 mg coated tablets containing oxycodone hydrochloride, manufactured by Protega Pharmaceuticals Inc. The label indicates this is a prescription-only oral tablet product, packaged as 100 tablets. It includes storage instructions, a barcode, and tablet identification markings to verify authenticity.*
FDA Label Image

Principal Display Panel – 10 mg Bottle Label (Rox02 0010 07)

Principal Display Panel – 10 mg Bottle Label (Rox02 0010 07)
RoxyBond 10 mg coated tablets packaging label showing oxycodone hydrochloride as the active ingredient. The label indicates 100 tablets in the container, with instructions for storage between 15°C and 30°C and warnings to protect from moisture. The product is manufactured by Protega Pharmaceuticals Inc., Princeton, NJ. The label includes a tablet identification diagram and a note to provide an accompanying medication guide upon dispensing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.